Giles Robinson: We’re enrolling infants and young children with medulloblastoma on SJiMB21

Giles Robinson, Neuro-Oncology Division Director at the St. Jude Children’s Research Hospital, shared on X/Twitter:

“Medulloblastoma is the most common malignant childhood brain tumor. We’re enrolling infants and young children with medulloblastoma on SJiMB21, a trial that tailors treatment based on the tumor’s molecular group, subgroup and clinical risk.”

For more details, click here.
Source: Giles Robinson/X